University of Illinois at Chicago
Announcement of an Exempt Purchase
Baxter HealthcareDeerfield, IL
- Amount: An estimated $2,500,000
- Terms: An estimated start date of 7/1/2022 through 6/30/2025
- Renewals: None
0 BEP vendors
0 VBP vendors
0 Small businesses
The University award process may be delayed up to thirty days as this award goes through a state approval process.
First published Monday, April 18, 2022
The University awarded a contract for Prismasol.
Prismasol is for continuous renal replacement therapy (CRRT) is a common modality for management of acute renal failure in critically ill patients. This therapy provides slow removal of fluids and solutes intended to substitute for impaired renal function over an extended period of time.
This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for medical supplies or medical services necessary for the delivery of care and treatment at medical, dental, or veterinary teaching facilities utilized by SIU or U of I (30 ILCS 500 / 1-13(b-5)) Prismasol renal replacement solution is indicated for use as replacement solution in Continuous Renal Replacement Therapy to replace plasma volumed removed by ultrafiltration and to correct electrolyte and acid-base imbalances in critially ill patients. This is a common modality for patients in acute renal failure which provides slow removal of fluids and solutes intended to substitute for impaired kidney function.
For instructions on how to obtain a comprehensive purchase description, disclosure or contract forms, contact:
The State of Illinois has a policy to encourage prospective vendors to hire
qualified veterans, minorities, females, persons with disabilities and ex-offenders.